TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 96nMAssay Description:Competitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 310nMAssay Description:Uncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 320nMAssay Description:Mixed inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 480nMAssay Description:Noncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 2.90E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 4.10E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 4.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.20E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.21E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair